• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE".针对重症冠状病毒病-19潜在发病机制提出的新命名法：“免疫性内皮炎伴炎性血栓形成-ITIE”
Rheumatol Int. 2021 Mar;41(3):679-680. doi: 10.1007/s00296-020-04768-1. Epub 2021 Jan 3.
2
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
3
A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19.一种新的炎症性微血栓形成综合征可解释新冠病毒疾病患者的血栓形成并发症
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):115-116. doi: 10.1016/j.rec.2020.08.021. Epub 2020 Oct 2.
4
Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.严重急性呼吸综合征冠状病毒2感染网络的数学建模，涉及细胞因子风暴、氧化应激、血栓形成、胰岛素抵抗和一氧化氮途径
OMICS. 2021 Dec;25(12):770-781. doi: 10.1089/omi.2021.0155. Epub 2021 Nov 22.
5
The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）的致病特征：免疫逃避的可能机制？
Front Immunol. 2021 Jul 14;12:693579. doi: 10.3389/fimmu.2021.693579. eCollection 2021.
6
A lipidomic view of SARS-CoV-2.SARS-CoV-2 的脂质组学观点。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20210953.
7
Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.社论：世界卫生组织（WHO）修订的关于 SARS-CoV-2 的关注变体和感兴趣变体的术语。
Med Sci Monit. 2021 Jun 21;27:e933622. doi: 10.12659/MSM.933622.
8
Platelets and COVID-19.血小板与 COVID-19。
Hamostaseologie. 2021 Oct;41(5):379-385. doi: 10.1055/a-1581-4355. Epub 2021 Oct 25.
9
Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.新型冠状病毒肺炎急性呼吸功能障碍中的免疫血栓形成。
Front Immunol. 2021 Jun 2;12:651545. doi: 10.3389/fimmu.2021.651545. eCollection 2021.
10
COVID-19 epidemic: anticoagulants treatments, another victim.新冠疫情：抗凝治疗，又一受害者。
Acta Cardiol. 2021 Apr;76(2):222-223. doi: 10.1080/00015385.2020.1810916. Epub 2020 Dec 14.

引用本文的文献

1
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study.新型冠状病毒肺炎凝血病是血栓性微血管病吗？一项前瞻性观察性研究。
Int J Mol Sci. 2025 Jun 4;26(11):5395. doi: 10.3390/ijms26115395.
2
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的黑色素瘤和肾细胞癌患者的 COVID-19 的临床和免疫学意义。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002835.
3
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.比较镰状细胞病患者与医护人员 COVID-19 感染的临床病程。
Ann Hematol. 2021 Sep;100(9):2195-2202. doi: 10.1007/s00277-021-04549-1. Epub 2021 May 25.
4
COVID-19 and thrombotic microangiopathies.COVID-19 与血栓性微血管病。
Thromb Res. 2021 Jun;202:191-198. doi: 10.1016/j.thromres.2021.04.012. Epub 2021 Apr 20.
5
COVID-19 and the clinical course of rheumatic manifestations.COVID-19 与风湿表现的临床病程。
Clin Rheumatol. 2021 Jul;40(7):2611-2619. doi: 10.1007/s10067-021-05691-x. Epub 2021 Mar 17.

本文引用的文献

1
Circulating markers of angiogenesis and endotheliopathy in COVID-19.新冠病毒病中血管生成和内皮病变的循环标志物
Pulm Circ. 2020 Nov 25;10(4):2045894020966547. doi: 10.1177/2045894020966547. eCollection 2020 Oct-Dec.
2
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19.新型冠状病毒肺炎中动脉和静脉血栓形成的诊断、管理及病理生理学
JAMA. 2020 Dec 22;324(24):2548-2549. doi: 10.1001/jama.2020.23422.
3
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.新型冠状病毒肺炎相关过度炎症综合征的临床标准：一项队列研究
Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.
4
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
5
A review of the main histopathological findings in coronavirus disease 2019.2019年冠状病毒病主要组织病理学发现综述
Hum Pathol. 2020 Nov;105:74-83. doi: 10.1016/j.humpath.2020.07.023. Epub 2020 Aug 2.
6
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗？
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
7
COVID-19: the vasculature unleashed.COVID-19：血管失控。
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
8
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
9
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.COVID-19 患者的临床特征、出院率和死亡率的荟萃分析。
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.

Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE".

作者信息

Bilgin Emre, Ertenli Ali İhsan

机构信息

Division of Rheumatology, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Rheumatol Int. 2021 Mar;41(3):679-680. doi: 10.1007/s00296-020-04768-1. Epub 2021 Jan 3.

DOI:10.1007/s00296-020-04768-1
PMID:33388970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7778855/
Abstract
摘要